We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
(+24%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
7.43%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$115M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$93.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$57.1M |
| 4 |
Eli Lilly
LLY
|
+$51.1M |
| 5 |
Qorvo
QRVO
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.5M |
| 3 |
Amazon
AMZN
|
+$65.6M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.8M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.9% |
| 2 | Technology | 32.83% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 3.92% |
| 5 | Consumer Discretionary | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Arrowhead Research
ARWR
$12.3B
| – | – |
-87,365
| Closed | -$3.76M |
|
|
LONA
227
LeonaBio Inc
LONA
$72.1M
| – | – |
-7,252
| Closed | -$1.34M |
|
228
Alibaba
BABA
$308B
| – | – |
-115,217
| Closed | -$33.9M |
|
229
Baidu
BIDU
$37.7B
| – | – |
-109,546
| Closed | -$13.9M |
|
|
230
Bristol-Myers Squibb
BMY
$130B
| – | – |
-1,103,742
| Closed | -$66.5M |
|
231
BellRing Brands
BRBR
$1.47B
| – | – |
-147,234
| Closed | -$3.05M |
|
232
Cadence Design Systems
CDNS
$92.8B
| – | – |
-37,474
| Closed | -$4M |
|
233
Cigna
CI
$71.5B
| – | – |
-223,850
| Closed | -$37.9M |
|
234
Cinemark Holdings
CNK
$4.38B
| – | – |
-26,987
| Closed | -$270K |
|
|
VISN
235
Vistance Networks Inc
VISN
$2.79B
| – | – |
-514,299
| Closed | -$4.63M |
|
236
CVS Health
CVS
$126B
| – | – |
-61,476
| Closed | -$3.59M |
|
237
Dell
DELL
$299B
| – | – |
-93,568
| Closed | -$3.21M |
|
238
Quest Diagnostics
DGX
$26B
| – | – |
-142,339
| Closed | -$16.3M |
|
239
DaVita
DVA
$12B
| – | – |
-55,720
| Closed | -$4.77M |
|
240
Euronet Worldwide
EEFT
$2.78B
| – | – |
-173,432
| Closed | -$15.8M |
|
241
F5
FFIV
$23.4B
| – | – |
-68,995
| Closed | -$8.47M |
|
242
Flex
FLEX
$45B
| – | – |
-1,035,060
| Closed | -$8.69M |
|
243
JFrog
FROG
$10.2B
| – | – |
-30,000
| Closed | -$2.54M |
|
244
Herbalife
HLF
$1.31B
| – | – |
-32,669
| Closed | -$1.52M |
|
245
HealthEquity
HQY
$8.73B
| – | – |
-61,006
| Closed | -$3.13M |
|
246
Humana
HUM
$43.7B
| – | – |
-54,262
| Closed | -$22.5M |
|
247
Icon
ICLR
$12.6B
| – | – |
-23,580
| Closed | -$4.51M |
|
248
Idexx Laboratories
IDXX
$46.1B
| – | – |
-63,661
| Closed | -$25M |
|
249
Intel
INTC
$510B
| – | – |
-85,814
| Closed | -$4.44M |
|
250
iShares Russell 2000 ETF
IWM
$82.5B
| – | – |
-81,218
| Closed | -$12.2M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.
- Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
- Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
- Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
- Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
- Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
- Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
- Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.
Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.